rs75847960
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_033028.5(BBS4):c.1451-45T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.11 in 1,501,516 control chromosomes in the GnomAD database, including 10,093 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.085 ( 668 hom., cov: 32)
Exomes 𝑓: 0.11 ( 9425 hom. )
Consequence
BBS4
NM_033028.5 intron
NM_033028.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.127
Publications
4 publications found
Genes affected
BBS4 (HGNC:969): (Bardet-Biedl syndrome 4) This gene is a member of the Bardet-Biedl syndrome (BBS) gene family. Bardet-Biedl syndrome is an autosomal recessive disorder characterized by severe pigmentary retinopathy, obesity, polydactyly, renal malformation and cognitive disability. The proteins encoded by BBS gene family members are structurally diverse. The similar phenotypes exhibited by mutations in BBS gene family members are likely due to the protein's shared roles in cilia formation and function. Many BBS proteins localize to the basal bodies, ciliary axonemes, and pericentriolar regions of cells. BBS proteins may also be involved in intracellular trafficking via microtubule-related transport. The protein encoded by this gene has sequence similarity to O-linked N-acetylglucosamine (O-GlcNAc) transferases in plants and archaebacteria and in human forms a multi-protein "BBSome" complex with seven other BBS proteins. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Mar 2016]
BBS4 Gene-Disease associations (from GenCC):
- Bardet-Biedl syndrome 4Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, G2P
- ciliopathyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- Bardet-Biedl syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.74).
BP6
Variant 15-72737433-T-C is Benign according to our data. Variant chr15-72737433-T-C is described in ClinVar as Likely_benign. ClinVar VariationId is 21732.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.116 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| BBS4 | NM_033028.5 | c.1451-45T>C | intron_variant | Intron 15 of 15 | ENST00000268057.9 | NP_149017.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| BBS4 | ENST00000268057.9 | c.1451-45T>C | intron_variant | Intron 15 of 15 | 1 | NM_033028.5 | ENSP00000268057.4 |
Frequencies
GnomAD3 genomes AF: 0.0849 AC: 12916AN: 152142Hom.: 668 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
12916
AN:
152142
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0813 AC: 16024AN: 196986 AF XY: 0.0842 show subpopulations
GnomAD2 exomes
AF:
AC:
16024
AN:
196986
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.113 AC: 152567AN: 1349256Hom.: 9425 Cov.: 20 AF XY: 0.112 AC XY: 75334AN XY: 671982 show subpopulations
GnomAD4 exome
AF:
AC:
152567
AN:
1349256
Hom.:
Cov.:
20
AF XY:
AC XY:
75334
AN XY:
671982
show subpopulations
African (AFR)
AF:
AC:
1662
AN:
31204
American (AMR)
AF:
AC:
2011
AN:
39758
Ashkenazi Jewish (ASJ)
AF:
AC:
2632
AN:
24874
East Asian (EAS)
AF:
AC:
6
AN:
38318
South Asian (SAS)
AF:
AC:
7148
AN:
79708
European-Finnish (FIN)
AF:
AC:
2805
AN:
51088
Middle Eastern (MID)
AF:
AC:
502
AN:
5564
European-Non Finnish (NFE)
AF:
AC:
129733
AN:
1022254
Other (OTH)
AF:
AC:
6068
AN:
56488
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.510
Heterozygous variant carriers
0
6821
13642
20463
27284
34105
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
4600
9200
13800
18400
23000
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0849 AC: 12924AN: 152260Hom.: 668 Cov.: 32 AF XY: 0.0810 AC XY: 6027AN XY: 74452 show subpopulations
GnomAD4 genome
AF:
AC:
12924
AN:
152260
Hom.:
Cov.:
32
AF XY:
AC XY:
6027
AN XY:
74452
show subpopulations
African (AFR)
AF:
AC:
2247
AN:
41556
American (AMR)
AF:
AC:
933
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
AC:
380
AN:
3472
East Asian (EAS)
AF:
AC:
3
AN:
5184
South Asian (SAS)
AF:
AC:
391
AN:
4826
European-Finnish (FIN)
AF:
AC:
640
AN:
10612
Middle Eastern (MID)
AF:
AC:
22
AN:
294
European-Non Finnish (NFE)
AF:
AC:
8026
AN:
68006
Other (OTH)
AF:
AC:
180
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
578
1157
1735
2314
2892
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
156
312
468
624
780
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
124
AN:
3478
ClinVar
Significance: Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Bardet-Biedl syndrome Benign:1
Oct 13, 2009
GeneReviews
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:curation
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.